Apichope Pharmaceutical Group Co.,Ltd.(300723),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

300723 Apichope Pharmaceutical Group Co.,Ltd.

Closed 12-31 15:00:00

33.55

-0.56

-1.64%

High34.35	Low33.48	Vol7.49M
Open34.15	D1 Closing34.11	Amplitude2.55%
Mkt Cap15.16B	Tradable Cap14.02B	Total Shares452.00M
T/O252.00M	T/O Rate1.79%	Tradable Shares418.00M
P/B8.8	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"300723","market":"SZ","secType":"STK","nameCN":"Apichope Pharmaceutical Group Co.,Ltd.","latestPrice":33.55,"timestamp":1767164580000,"preClose":34.11,"halted":0,"volume":7493901,"delay":0,"changeRate":-0.0164,"floatShares":418000000,"shares":451999999,"eps":-0.9511,"marketStatus":"Closed","change":-0.56,"latestTime":"12-31 15:00:00","open":34.15,"high":34.35,"low":33.48,"amount":252000000,"amplitude":0.0255,"askPrice":33.55,"askSize":114,"bidPrice":33.54,"bidSize":96,"shortable":0,"etf":0,"ttmEps":-0.9511,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1767576600000},"marketStatusCode":5,"adr":0,"adjPreClose":34.11,"symbolType":"stock","openAndCloseTimeList":[[1767144600000,1767151800000],[1767157200000,1767164400000]],"highLimit":37.52,"lowLimit":30.7,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":451692766,"isCdr":false,"pbRate":8.8,"roa":"--","roe":"--","epsLYR":-1.1956,"committee":0.260032,"marketValue":15154000000,"turnoverRate":0.0179,"status":1,"floatMarketCap":14013000000},"requestUrl":"/m/hq/s/300723/tweets","defaultTab":"tweets","newsList":[{"id":"1142176013","title":"Apichope Pharmaceutical Group's Subsidiary Obtains Registration Certificate for Sodium Valproate Concentrated Injection Solution","url":"https://stock-news.laohu8.com/highlight/detail?id=1142176013","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142176013?lang=en_us&edition=fundamental","pubTime":"2025-12-23 16:00","pubTimestamp":1766476815,"startTime":"0","endTime":"0","summary":"Apichope Pharmaceutical Group Co., Ltd. (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou Lianrui Pharmaceutical Co., Ltd., recently received the Drug Registration Certificate for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300723","BK0239"],"gpt_icon":0},{"id":"1102200295","title":"Apichope Pharmaceutical Group Donates Medical Supplies to Yangshan County's Dalang Town","url":"https://stock-news.laohu8.com/highlight/detail?id=1102200295","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102200295?lang=en_us&edition=fundamental","pubTime":"2025-12-19 13:12","pubTimestamp":1766121125,"startTime":"0","endTime":"0","summary":"Recently, the \"Government-Enterprise Joint Initiative for Rural Healthcare – Dalang Town Medical Donation Ceremony,\" guided by the Guangzhou Development District's Business Environment Reform Bureau,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159891","BK0239","300723"],"gpt_icon":0},{"id":"1165489665","title":"Apichope Sells Gout Drug Stake: What Now for Its Stock Price?","url":"https://stock-news.laohu8.com/highlight/detail?id=1165489665","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165489665?lang=en_us&edition=fundamental","pubTime":"2025-12-16 21:00","pubTimestamp":1765890036,"startTime":"0","endTime":"0","summary":"Apichope Pharmaceutical Group (300723.SZ) has sold what many considered its \"golden goose.\" On December 16, the company announced its wholly-owned subsidiary would divest its 13.45% stake in...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","159992","BK1574","BK1161","06978","300723"],"gpt_icon":0},{"id":"1149155940","title":"Apichope Pharmaceutical Shares Plunge Over 12% During Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1149155940","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149155940?lang=en_us&edition=fundamental","pubTime":"2025-12-16 11:41","pubTimestamp":1765856468,"startTime":"0","endTime":"0","summary":"Despite announcing a share buyback plan, Apichope Pharmaceutical Group Co.,Ltd. (300723) saw its stock price decline sharply on December 16. The shares opened 4.34% lower and continued to drop during...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300723","BK0239"],"gpt_icon":0},{"id":"1138129211","title":"Apichope Pharmaceutical Plunges 20% After Announcing Sale of Gout Drug Subsidiary Stake; Company Launches Emergency Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=1138129211","media":"Deep News","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138129211?lang=en_us&edition=fundamental","pubTime":"2025-12-15 23:00","pubTimestamp":1765810844,"startTime":"0","endTime":"0","summary":"On December 15, Apichope Pharmaceutical Group Co., Ltd. (300723), a high-flying biotech stock that had surged over 400% this year, saw its shares crash with a rare 20% limit-down drop. Post-market...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","159992","BK1574","BK1161","06978","300723"],"gpt_icon":0},{"id":"2591061198","title":"ApicHope Pharmaceutical Gets Nod for Qinxiang Qingjie Oral Liquid to Be Protected Traditional Chinese Medicine Variety","url":"https://stock-news.laohu8.com/highlight/detail?id=2591061198","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591061198?lang=en_us&edition=fundamental","pubTime":"2025-12-15 16:55","pubTimestamp":1765788940,"startTime":"0","endTime":"0","summary":"ApicHope Pharmaceutical , through a subsidiary, received approval from China's National Medical Products Administration for the Qinxiang Qingjie Oral Liquid to become a Class II protected traditional Chinese medicine variety, according to a Shenzhen bourse disclosure on Saturday.The pharmaceutical company's shares dipped 20% at the close of Monday's trade.The drug is mainly used for children with upper respiratory tract infections with symptoms of both external and internal heat.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["300723","BK0239"],"gpt_icon":0},{"id":"2590508917","title":"ApicHope Pharmaceutical's Guangzhou Subsidiary Gets Drug Certificate for Antibiotic","url":"https://stock-news.laohu8.com/highlight/detail?id=2590508917","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590508917?lang=en_us&edition=fundamental","pubTime":"2025-12-12 19:04","pubTimestamp":1765537465,"startTime":"0","endTime":"0","summary":"Chinese drug regulators granted ApicHope Pharmaceutical  subsidiary Guangzhou ApicHope Pharmaceutical a drug registration certificate for its levofloxacin oral solution, according to a Friday filing with the Shenzhen bourse.The antibiotic is indicated for bacterial infections such as hospital- and community-acquired pneumonia, bacterial sinusitis, bacterial exacerbation of chronic bronchitis, skin infections, uncomplicated urinary tract infections, pyelonephritis, and inhalation anthrax, the filing said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","300723"],"gpt_icon":0},{"id":"1119196321","title":"Apichope Pharmaceutical Group's Subsidiary Obtains Registration Certificate for Levofloxacin Oral Solution","url":"https://stock-news.laohu8.com/highlight/detail?id=1119196321","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119196321?lang=en_us&edition=fundamental","pubTime":"2025-12-11 15:50","pubTimestamp":1765439421,"startTime":"0","endTime":"0","summary":"Apichope Pharmaceutical Group Co., Ltd. (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou Apichope Pharmaceutical Co., Ltd., recently received the Drug Registration Certificate for...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300723","BK0239"],"gpt_icon":0},{"id":"1128977176","title":"Apichope Pharmaceutical Group (300723.SZ) Obtains Registration Certificate for Esomeprazole Magnesium Enteric Dry Suspension","url":"https://stock-news.laohu8.com/highlight/detail?id=1128977176","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128977176?lang=en_us&edition=fundamental","pubTime":"2025-11-28 16:24","pubTimestamp":1764318252,"startTime":"0","endTime":"0","summary":"Apichope Pharmaceutical Group Co., Ltd. (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou Apichope Pharmaceutical Co., Ltd., recently received the Drug Registration Certificate for...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300723","BK0239"],"gpt_icon":0},{"id":"1146459183","title":"Apichope Pharmaceutical Group (300723.SZ) Obtains Registration Certificate for Pentoxifylline Sustained-Release Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=1146459183","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146459183?lang=en_us&edition=fundamental","pubTime":"2025-11-28 16:20","pubTimestamp":1764318020,"startTime":"0","endTime":"0","summary":"Apichope Pharmaceutical Group Co., Ltd. (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou Lianrui Pharmaceutical Co., Ltd., recently received the Drug Registration Certificate for...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300723","BK0239"],"gpt_icon":0},{"id":"1122978322","title":"Apichope Pharmaceutical Faces 528 Million Yuan Patent Dispute, Highlighting Pain Points in Pharma Industry Transformation","url":"https://stock-news.laohu8.com/highlight/detail?id=1122978322","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122978322?lang=en_us&edition=fundamental","pubTime":"2025-11-28 16:00","pubTimestamp":1764316840,"startTime":"0","endTime":"0","summary":"Recently, listed pharmaceutical company Apichope Pharmaceutical Group Co.,Ltd. announced it has been sued by Huiyou International Limited for intellectual property disputes, with a claimed...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300723","BK0239"],"gpt_icon":0},{"id":"2586444545","title":"ApicHope Pharmaceutical's Unit Gets Registration Certificate for Alzheimer's Treatment Drug: Shares Up 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586444545","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586444545?lang=en_us&edition=fundamental","pubTime":"2025-11-25 14:45","pubTimestamp":1764053126,"startTime":"0","endTime":"0","summary":"ApicHope Pharmaceutical's  unit, Guangzhou Yipinhong Pharmaceutical, obtained a drug registration certificate from China's National Medical Products Administration for the rivastigmine bitartrate oral solution, according to a Shenzhen bourse filing on Tuesday.It's a drug to help treat those with Alzheimer's, the filing said.The pharmaceutical company's shares soared 9% during the afternoon trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["300723","BK0239"],"gpt_icon":0},{"id":"1190536093","title":"Apichope Pharmaceutical Group (300723.SZ) Obtains Drug Registration Certificate for Rivastigmine Hydrogen Tartrate Oral Solution","url":"https://stock-news.laohu8.com/highlight/detail?id=1190536093","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190536093?lang=en_us&edition=fundamental","pubTime":"2025-11-24 17:24","pubTimestamp":1763976254,"startTime":"0","endTime":"0","summary":"Apichope Pharmaceutical Group Co., Ltd. (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou Apichope Pharmaceutical Co., Ltd., recently received the Drug Registration Certificate for...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300723","BK0239"],"gpt_icon":0},{"id":"1108351038","title":"Apichope Pharmaceutical Group (300723.SZ) Reports Net Loss of 136 Million Yuan for First Three Quarters","url":"https://stock-news.laohu8.com/highlight/detail?id=1108351038","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108351038?lang=en_us&edition=fundamental","pubTime":"2025-10-29 22:42","pubTimestamp":1761748930,"startTime":"0","endTime":"0","summary":"Apichope Pharmaceutical Group Co., Ltd. (300723.SZ) announced its third-quarter financial results for 2025. The company reported operating revenue of 814 million yuan for the first nine months,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","300723"],"gpt_icon":1},{"id":"2576400834","title":"ApicHope Pharmaceutical Unit Gets China Approval for Muscle Weakness Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2576400834","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576400834?lang=en_us&edition=fundamental","pubTime":"2025-10-20 17:13","pubTimestamp":1760951590,"startTime":"0","endTime":"0","summary":"China's National Medical Products Administration approved the neostigmine methylsulfate injection produced by ApicHope Pharmaceutical  subsidiary Guangzhou Lianrui Pharmaceutical, according to a Saturday filing with the Shenzhen bourse.Shares closed 1% lower on Monday.The drug is indicated for the treatment of myasthenia gravis or weakness in voluntary muscles, postoperative flatulence or farting, and urinary retention, the filing said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["300723","BK0239"],"gpt_icon":0},{"id":"1164823218","title":"Apichope Pharmaceutical Group Co., Ltd. (300723.SZ) Subsidiary Receives Registration Certificate for Methanesulfonic Acid Sugammadex Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1164823218","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164823218?lang=en_us&edition=fundamental","pubTime":"2025-10-17 15:58","pubTimestamp":1760687896,"startTime":"0","endTime":"0","summary":"Zhichun Finance APP reported that Apichope Pharmaceutical Group Co., Ltd. (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou Lianrui Pharmaceutical Co., Ltd., has recently received the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300723","BK0239"],"gpt_icon":0},{"id":"2571772598","title":"ApicHope Pharmaceutical Gets China Approval for L-Carnitine Solution","url":"https://stock-news.laohu8.com/highlight/detail?id=2571772598","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571772598?lang=en_us&edition=fundamental","pubTime":"2025-09-29 11:36","pubTimestamp":1759116961,"startTime":"0","endTime":"0","summary":"China's medical products administrator approved ApicHope Pharmaceutical's  Levocarnitine oral solution, according to a Monday filing with the Shenzhen bourse.The product treats primary systemic carnitine deficiency shown in Reye's encephalopathy or a rare swelling in the liver or the brain, hypoketotic hypoglycemia or low blood sugar and ketones, and/or cardiomyopathy or difficulty in heart pumping, the filing said.Shares jumped 2% during morning trading on Monday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","300723"],"gpt_icon":0},{"id":"2569769307","title":"ApicHope Pharmaceutical Gets Clinical Trial Approval for Fuganlin Granules; Shares Fall 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569769307","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569769307?lang=en_us&edition=fundamental","pubTime":"2025-09-23 13:29","pubTimestamp":1758605362,"startTime":"0","endTime":"0","summary":"ApicHope Pharmaceutical  subsidiary Yipinhong Pharmaceutical received approval from China's drug administrator to conduct clinical trials of fuganlin granules.The drug targets adult Qi-deficiency-type common cold, according to a Tuesday filing with the Shanghai bourse.Shares of the pharmaceutical company were down 4% in recent trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["300723","BK0239"],"gpt_icon":0},{"id":"1147212322","title":"Apichope Pharmaceutical Group (300723.SZ): Fuganlin Granules Receives Clinical Trial Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1147212322","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147212322?lang=en_us&edition=fundamental","pubTime":"2025-09-22 19:46","pubTimestamp":1758541581,"startTime":"0","endTime":"0","summary":"Apichope Pharmaceutical Group Co.,Ltd. (300723.SZ) announced that its wholly-owned subsidiary Guangzhou Apichope Pharmaceutical Co., Ltd. has recently received a Drug Clinical Trial Approval Notice...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","300723"],"gpt_icon":0},{"id":"1154748835","title":"Apichope Pharmaceutical Group (300723.SZ) Subsidiary Receives Approval Notice for Oseltamivir Phosphate Capsules Drug Supplement Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1154748835","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154748835?lang=en_us&edition=fundamental","pubTime":"2025-09-19 11:54","pubTimestamp":1758254059,"startTime":"0","endTime":"0","summary":"Apichope Pharmaceutical Group Co.,Ltd. (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou Apichope Pharmaceutical Co., Ltd. (\"Apichope Pharmaceutical\"), recently received the \"Drug...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300723","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2017-11-16","address":"广东省广州市黄埔区广州国际生物岛寰宇一路27号云润大厦17层","stockEarnings":[{"period":"1week","weight":-0.0384},{"period":"1month","weight":-0.3196},{"period":"3month","weight":-0.4355},{"period":"6month","weight":-0.4073},{"period":"1year","weight":0.9666},{"period":"ytd","weight":0.9666}],"companyName":"一品红药业集团股份有限公司","boardCode":"AI0027","perCapita":"20511股","boardName":"医药制造业","registeredCapital":"45169万元","compareEarnings":[{"period":"1week","weight":0.0071},{"period":"1month","weight":0.014},{"period":"3month","weight":0.0222},{"period":"6month","weight":0.143},{"period":"1year","weight":0.1841},{"period":"ytd","weight":0.1841}],"survey":"　　一品红药业集团股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是化学药(含原料药和制剂)、特色中成药等。公司曾先后获得中国化药研发综合实力百强企业、中国创新力医药企业100强和中国化药企业百强企业等荣誉称号，是广州生物医药产业链的链主企业。","serverTime":1767526044212,"listedPrice":17.05,"stockholders":"20363人(较上一季度减少1.73%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Apichope Pharmaceutical Group Co.,Ltd.(300723),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Apichope Pharmaceutical Group Co.,Ltd.(300723) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Apichope Pharmaceutical Group Co.,Ltd.,300723,Apichope Pharmaceutical Group Co.,Ltd.股票,Apichope Pharmaceutical Group Co.,Ltd.股票老虎,Apichope Pharmaceutical Group Co.,Ltd.股票老虎国际,Apichope Pharmaceutical Group Co.,Ltd.行情,Apichope Pharmaceutical Group Co.,Ltd.股票行情,Apichope Pharmaceutical Group Co.,Ltd.股价,Apichope Pharmaceutical Group Co.,Ltd.股市,Apichope Pharmaceutical Group Co.,Ltd.股票价格,Apichope Pharmaceutical Group Co.,Ltd.股票交易,Apichope Pharmaceutical Group Co.,Ltd.股票购买,Apichope Pharmaceutical Group Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Apichope Pharmaceutical Group Co.,Ltd.(300723),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Apichope Pharmaceutical Group Co.,Ltd.(300723) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}